DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,361,714 | +3.9% | 9,519 | +0.5% | 0.52% | +10.7% |
| Q2 2023 | $2,273,019 | -4.9% | 9,471 | -0.1% | 0.47% | -10.2% |
| Q1 2023 | $2,390,337 | -9.1% | 9,484 | -4.3% | 0.52% | -10.3% |
| Q4 2022 | $2,630,302 | +7.2% | 9,910 | +4.3% | 0.58% | -2.3% |
| Q3 2022 | $2,454,000 | +2.0% | 9,500 | +0.1% | 0.60% | +5.1% |
| Q2 2022 | $2,406,000 | -14.1% | 9,492 | -0.6% | 0.57% | +3.5% |
| Q1 2022 | $2,801,000 | -5.3% | 9,550 | +6.2% | 0.55% | +0.4% |
| Q4 2021 | $2,958,000 | +6.1% | 8,992 | -1.9% | 0.55% | -3.0% |
| Q3 2021 | $2,789,000 | +26.5% | 9,163 | +11.6% | 0.56% | +28.8% |
| Q2 2021 | $2,204,000 | +18.2% | 8,214 | -0.8% | 0.44% | +12.3% |
| Q1 2021 | $1,865,000 | +0.5% | 8,284 | -0.8% | 0.39% | -4.2% |
| Q4 2020 | $1,855,000 | +7.9% | 8,351 | +4.6% | 0.41% | -9.0% |
| Q3 2020 | $1,719,000 | +19.4% | 7,981 | -2.0% | 0.45% | +10.1% |
| Q2 2020 | $1,440,000 | +37.9% | 8,145 | +7.9% | 0.40% | +22.4% |
| Q1 2020 | $1,044,000 | +5.2% | 7,546 | +16.7% | 0.33% | +54.0% |
| Q4 2019 | $992,000 | +5.9% | 6,466 | -0.3% | 0.22% | -1.8% |
| Q3 2019 | $937,000 | +0.3% | 6,486 | -0.8% | 0.22% | +0.5% |
| Q2 2019 | $934,000 | +8.9% | 6,538 | +0.6% | 0.22% | +14.7% |
| Q1 2019 | $858,000 | +27.9% | 6,499 | -0.1% | 0.19% | +13.1% |
| Q4 2018 | $671,000 | -5.8% | 6,505 | -0.8% | 0.17% | +15.1% |
| Q3 2018 | $712,000 | +9.2% | 6,557 | -0.8% | 0.15% | +2.1% |
| Q2 2018 | $652,000 | -1.5% | 6,612 | -2.2% | 0.14% | -4.0% |
| Q1 2018 | $662,000 | +12.6% | 6,764 | +6.7% | 0.15% | +16.4% |
| Q4 2017 | $588,000 | +9.7% | 6,340 | +1.5% | 0.13% | +5.8% |
| Q3 2017 | $536,000 | +8.7% | 6,246 | +6.9% | 0.12% | +7.1% |
| Q2 2017 | $493,000 | -2.2% | 5,841 | -1.0% | 0.11% | +13.0% |
| Q1 2017 | $504,000 | +11.3% | 5,899 | +1.4% | 0.10% | +8.7% |
| Q4 2016 | $453,000 | +22.4% | 5,815 | +23.1% | 0.09% | +12.2% |
| Q3 2016 | $370,000 | -8.9% | 4,725 | +17.6% | 0.08% | -12.8% |
| Q2 2016 | $406,000 | +97.1% | 4,019 | +85.5% | 0.09% | +104.3% |
| Q1 2016 | $206,000 | – | 2,167 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |